A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: An association with systemic tumour necrosis factor α overexpression

British Journal of Dermatology

Volumn 141, Issue 1, 1999, Pages 94-102

  Asadullah, K ^a   Prosch S ^a   Audring, H ^a   Buttnerova L ^a   Volk, H D ^a   Sterry, W ^a   Docke, W D ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Chronic plaque psoriasis; Cytokines; Cytomegalovirus; Tumour necrosis factor

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; VIRUS REACTIVATION;

ADMINISTRATION, TOPICAL; ADULT; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; ANTIGENS, VIRAL; CALCITRIOL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYTOMEGALOVIRUS; DERMATOLOGIC AGENTS; DNA, VIRAL; HUMANS; LEUKOCYTES, MONONUCLEAR; PHOTOTHERAPY; PREVALENCE; PSORIASIS; SKIN; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; VIRUS LATENCY;

EID: 0032854682     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02926.x     Document Type: Article

References (57)

1. Christophers E, Sterry W. Psoriasis. In: Dermatology in General Medicine, 4th Edn. (Fitzpatrick TB, Eisen AZ, Wolff K et al., eds). New York: McGraw-Hill, 1993:489-515.
2. Krueger GG, Duvic M. Epidemiology of psoriasis: Clinical issues. J Invest Dermatol 1994; 102: 14-18S.
3. Leung DYM, Travers JB, Giorno R et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96: 2106-12.
4. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
5. Yamamoto T, Katayama I, Nishioka K. Psoriasis and hepatitis C virus. Acta Derm Venereol (Stockh) 1995; 75: 482-3.
6. Chouela E, Abeldaño A, Panetta J et al. Hepatitis C virus antibody (anti-HCV1: Prevalence in psoriasis. Int J Dermatol 1996; 35: 797-9.
7. Mahoney SE, Duvic M, Nickoloff BJ et al. Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions. J Clin Invest 1991; 88: 174-85.
8. Obuch ML, Maurer TA, Beeker B, Berger TG. Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27: 667-73.
9. Duvie M, Crane MM, Conant M et al. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol 1994; 130:447-51.
10. Wiemers S, Krutmann J, Kapp A, Schöpf E. Postherpetic erythema exudativum multiforme with concomitant exacerbation of psoriasis vulgaris. Hautarzt 1990; 41: 506-8.
11. Krueger JG, Krone JF, Carter DM, Gottlieb AB. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990; 94: 135S-140S.
12. Ho M. Cytomegalovirus: Biology and Infection. 2nd Edn. New York: Plenum, 1991.
13. Patel R, Snydman DR, Rubin RH et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996; 61: 1279-89.
14. Reinke P, Fietze E, Ode-Hakim S et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 1737-8.
15. Pariser RJ. Histologically specific skin lesions in disseminated cytomegalovirus infection. J Am Acad Dermatol 1983; 9: 937-46.
16. Swanson S, Feldman PS. Cytomegalovirus infection initially diagnosed by skin biopsy. Am J Clin Pathol 1987; 87: 113-16.
17. Patterson JW, Broecker AH, Kornstein MJ, Mills AS. Cutaneous cytomegalovirus infection in a liver transplant patient. Diagnosis by in situ DNA hybridization. Am J Dermatopathol 1988; 10: 524-30.
18. Lee JY. Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am J Clin Pathol 1989; 92: 96-100.
19. Tomme BK, Bowers KE, Scott GA. Diagnosis of cutaneous cytomegalovirus infection: A review and report of a case. J Am Acad Dermatol 1991; 24: 860-7.
20. Grimes PE, Sevall JS, Vojdani A. Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitilige. J Am Acad Dermatol 1996; 35: 21-6.
21. Zhu J. Cytomegalovirus infection induces expression of 60 kD/Ro antigen on human keratinocytes. Lupus 1995; 4: 369-406.
22. Stein J, Volk HC, Liebenthal C et al. Tumour necrosis factor α stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol 1993; 74: 2333-8.
23. Döeke WD, Prösch S, Fietze E, et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343: 268-9.
24. Fietze E, Prösch S, Reinke P et al. Cytomegalovirus infection in transplant recipients. Transplantation 1994; 58: 675-80.
25. Beyaert R, Schulze-Osthoff K, van Roy F, Fiefs W. Synergistic induction of interleukin-6 by tumour necrosis factor and lithium chloride in mice: Possible role in the triggering and exacerbation of psoriasis by lithium treatment. Eur J Immunol 1992; 22: 2181-4.
26. Kristensen M, Chu CQ, Eedy DJ et al. Localization of tumour necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: Epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 1993; 94: 354-62.
27. Bonifati C, Carducci M, Cordiali Fei P et al. Correlated increases of tumour necrosis factor-α, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - Relationships with disease severity. Clin Exp Dermatol 1994; 19: 383-7.
28. Ettehadi P, Greaves MW, Wallach D et al, Elevated tumour necrosis Factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 1994; 96: 146-51.
29. Olaniran AK, Baker RS, Paige DC, et al. Cytokine expression in psoriatic skin lesions during PUVA therapy. Arch Dermatol Res 1996; 288: 421-5.
30. Olive DM, Simsek M, Al-Mufti SD. Polymerase chain reaction assay for detection of human cytomegaluvirus. J Clin Microbiol 1989; 27: 1238-42.
31. Prösch S, Kimel V, Dawydowa I, Krüger D, Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR. J Med Virol 1992; 38: 246-52.
32. Asadullah K, Döcke WD, Haeußler A et al. Progression of mycosis fungoides is associated with increasing cutaneous expression of IL-10 mRNA. J Invest Dermatol 1996; 107: 833-7.
33. Asadullah K, Sterry W, Sthephanek K et al. IL-10 is a key cytokine in psoriasis: Proof of principle by IL-10 therapy - A new therapeutic approach. J Clin Invest 1998; 101: 783-94.
34. Mocarski ES, Kemble GW, Lyle JM, Greaves RE. A deletion mutant in the human cytomegalovirus gene encoding 1E1 (491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci USA 1996; 93: 11321-6.
35. Prösch S, Staak K, Stein J et al. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFα is mediated via induction of NF-kB. Virol 1995; 208: 197-206.
36. Kondo K, Xu J, Mocarski ES. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 1996; 93: 11137-42.
37. Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996; 77: 3099-102.
38. Söderberg-Nauclér C, Fish KN, Nelson JA. Reactivation latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91: 119-26.
39. Staak K, Prösch S, Stein J et al. Pentoxilylline promötes replication on human cytomegalovirus in vivo and in vitro. Blood 1997; 89: 3682-90.
40. LeRoy F, Brown KA, Greaves MW et al. Blood mononuclear cells from patients with psoriasis exhibit an enhanced adherence to cultured vascular endothelium. J Invest Dermatol 1991; 97: 511-16.
41. Tigalonova M, Bjerke JR, Gallati H et al. Serum levels of interferons and TNF-α are not correlated to psoriasis activity and therapy. Acta Derm Venereol (Stockh) 1994; 186 (Suppl.): 25-7.
42. Borysiewicz K, Hickling JK, Graham S et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognising the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med 1988; 168: 919-31.
43. Greenberg PD, Reusser P, Goodrich JM, Riddell SR. Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro. Ann NY Acad Sci 1991; 636: 184-95.
44. Gavin MA, Gilbert MJ, Riddell SR et al. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class 1 MHC-restricted CTL epitopes. J Immunol 1993; 151: 3971-80.
45. McLaughlin-Taylor E, Pande H, Forman SJ et al. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 1994; 43: 103-10.
46. van Zanten J, Harmsen MC, van der Meer P et al. Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipients. J Infect Dis 1995; 172: 879-82.
47. Grundy JE. Current antiviral therapy fails to prevent the proinflammatory effects of cytomegalovirus infection, whilst rendering infected cells relatively resistant to immune attack. In: CMV-Related Immunopathology (Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr, eds). Basel: Karger, 1998: 67-89.
48. Crump JW, Geist LJ, Auron PE et al. The immediate early genes of human cytomegalovirus require only proximal promoter elements to upregulate expression of interleukin-1 beta. Am J Respir Cell Mol Biol 1992; 6: 674-7.
49. Iwamoto GK, Konicek SA. Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression. J Invest Med 1997; 45: 175-82.
50. Valdimarsson H, Baker BS, Johnsdottir I, Fry L. Psoriasis: A disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1986; 7: 256-9.
51. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol 1991; 127: 871-84.
52. Jeffes EW III, Lee GC, Said S et al. Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity. J Invest Dermatol 1995; 105: 733-8.
53. Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98: 1878-87.
54. Norris DA, Traves JB, Leung DYM. Lymphocyte activation in the pathogenesis of psoriasis. J Invest Dermatol 1997; 109: 1-4.
55. Dobrescu D, Ursea B, Pope M et al. Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen. Cell 1995; 82: 753-63.
56. Horn TD, Farmer ER, Vogelsang GB et al. Cutaneous graft-versus-host reaction lacks evidence of cutaneous cytomegalovirus by the immunoperoxidase technique. J Invest Dermatol 1989; 93: 92-5.
57. Appleton AL, Sviland L, Peiris JS et al. Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease. Bone Marrow Transplant 1995; 15: 557-61.